BioCentury
ARTICLE | Company News

Galderma sales and marketing update

February 18, 2013 8:00 AM UTC

Galderma launched Tri-Luma cream in the U.S. to treat moderate to severe melisma of the face for up to eight weeks. Tri-Luma is a topical combination of fluocinolone acetonide, a mild corticosteroid; ...